Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis published directly by a partner lab. Filter by peptide, vendor, lab, or test coverage. Each row links to the verified record — not a vendor-hosted copy.
← Swipe to see more columns →
| Vendor | Peptide | Lot | Lab | Purity | Tests | Provenance | Tested | |
|---|---|---|---|---|---|---|---|---|
| Instant Peptides | 2026-0270-C | Kovera Labs | 99.86% | MSLAL |
| Confirmed by Kovera Labs |
| 2026-04-19 |
| Stats only |
| Instant Peptides | 2025-0259-A | Freedom Diagnostics | 99.83% | MSLALUSP<71>HM | Confirmed by Freedom Diagnostics | 2026-04-19 | Stats only |
| Instant Peptides | 2025-0259-B | Freedom Diagnostics | 99.91% | MSLALUSP<71>HM | Confirmed by Freedom Diagnostics | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0259-A | Freedom Diagnostics | 99.96% | MSLALUSP<71>HM | Confirmed by Freedom Diagnostics | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0259-B | Freedom Diagnostics | 99.92% | MSLALUSP<71>HM | Confirmed by Freedom Diagnostics | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0259-C | Kovera Labs | 99.92% | MSLALUSP<71>HM | Confirmed by Kovera Labs | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0259-D | Kovera Labs | 99.86% | MSLALUSP<71>HM | Confirmed by Kovera Labs | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0259-E | Kovera Labs | 99.82% | MSLALUSP<71>HM | Confirmed by Kovera Labs | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0314-A | Kovera Labs | 99.94% | MSLALUSP<71>HM | Confirmed by Kovera Labs | 2026-04-19 | Stats only |
| Instant Peptides | 2025-0235-A | Freedom Diagnostics | 99.87% | MSLALUSP<71>HM | Vendor-published | 2026-04-19 | Stats only |
| Instant Peptides | 2025-0235-B | Freedom Diagnostics | 99.61% | MSLALUSP<71>HM | Vendor-published | 2026-04-19 | Stats only |
| Instant Peptides | 2025-0235-C | Freedom Diagnostics | 99.90% | MSLALUSP<71>HM | Confirmed by Freedom Diagnostics | 2026-04-19 | Stats only |
| Instant Peptides | 2025-0235-D | Freedom Diagnostics | 99.71% | MSLALUSP<71>HM | Confirmed by Freedom Diagnostics | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0235-B | Freedom Diagnostics | 99.94% | MSLALUSP<71>HM | Confirmed by Freedom Diagnostics | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0235-A | Freedom Diagnostics | 99.71% | MSLALUSP<71>HM | Confirmed by Freedom Diagnostics | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0235-C | Kovera Labs | 99.95% | MSLALUSP<71>HM | Confirmed by Kovera Labs | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0235-D | Kovera Labs | 99.86% | MSLALUSP<71>HM | Confirmed by Kovera Labs | 2026-04-19 | Stats only |
| Instant Peptides | 2026-0312-A | Kovera Labs | 99.92% | MSLALUSP<71>HM | Confirmed by Kovera Labs | 2026-04-19 | Stats only |
| EZ Peptides | EZP-KPV1004082026-11 | Janoshik Analytical | 99.71% | MSLALUSP<71>HM | Vendor-published | 2026-04-17 | View |
| EZ Peptides | EZP-SEL1004042026-07 | Janoshik Analytical | 99.60% | MSLALUSP<71>HM | Vendor-published | 2026-04-17 | View |
| EZ Peptides | EZP-BPCTB41004062026-03 | Janoshik Analytical | — | MSLALUSP<71>HM | Vendor-published | 2026-04-17 | View |
| EZ Peptides | EZP-TBF1004082026-04 | Janoshik Analytical | 99.87% | MSLALUSP<71>HM | Vendor-published | 2026-04-17 | View |
| Verified Peptides | M004261220K | Janoshik Analytical | 99.60% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-04-17 | View |
| Verified Peptides | GHK052614100N | Janoshik Analytical | 99.73% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-04-17 | View |
| Verified Peptides | — | Janoshik Analytical | 99.60% | MSLALUSP<71>HM | Vendor-published | 2026-04-17 | View |
| Verified Peptides | — | Janoshik Analytical | 99.60% | MSLALUSP<71>HM | Vendor-published | 2026-04-17 | View |
| Verified Peptides | — | Janoshik Analytical | 99.60% | MSLALUSP<71>HM | Vendor-published | 2026-04-17 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.26% | MSLALUSP<71>HM | Vendor-published | 2026-04-16 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.81% | MSLALUSP<71>HM | Vendor-published | 2026-04-16 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.66% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-04-16 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.02% | MSLALUSP<71>HM | Vendor-published | 2026-04-16 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.53% | MSLALUSP<71>HM | Vendor-published | 2026-04-16 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.88% | MSLALUSP<71>HM | Vendor-published | 2026-04-16 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.96% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-04-16 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.84% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-04-16 | View |
| Reta Peptide | 20260409 | Janoshik Analytical | 99.38% | MSLALUSP<71>HM | Confirmed by Janoshik Analytical | 2026-04-16 | View |
| NG Peptide | SL05 | ILS Labs | 99.68% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-04-16 | View |
| NG Peptide | CJPA10-03 | ILS Labs | 99.60% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-04-16 | View |
| NG Peptide | RT30-6173 | ILS Labs | 99.96% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-04-16 | View |
| NG Peptide | TS;PA-1736 | ILS Labs | 99.98% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-04-16 | View |
| NG Peptide | RT10-0429 | ILS Labs | 99.30% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-04-16 | View |
| NG Peptide | RT20-3618 | ILS Labs | 99.80% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-04-16 | View |
| NG Peptide | PT10-1639 | ILS Labs | 99.95% | MSLALUSP<71>HM | Vendor-published | 2026-04-16 | View |
| NG Peptide | TSM11 | ILS Labs | 99.40% | MSLALUSP<71>HM | Confirmed by ILS Labs | 2026-04-16 | View |
| OROS Research | OR-LPTESIPA20-426-B3 | Ethos Analytics | 99.00% | MSLALUSP<71>HM | Confirmed by Ethos Analytics | 2026-04-16 | View |
| OROS Research | OR-LPSERM5-426-B4 | Ethos Analytics | 99.00% | MSLALUSP<71>HM | Confirmed by Ethos Analytics | 2026-04-16 | View |
| OROS Research | OR-LPMT2-426-B5 | Ethos Analytics | 99.00% | MSLALUSP<71>HM | Confirmed by Ethos Analytics | 2026-04-16 | View |
| OROS Research | OR-LPMOTS10-426-B7 | Ethos Analytics | 99.00% | MSLALUSP<71>HM | Confirmed by Ethos Analytics | 2026-04-16 | View |
| OROS Research | OR-LPKPV15-426-B2 | Ethos Analytics | 99.00% | MSLALUSP<71>HM | Confirmed by Ethos Analytics | 2026-04-16 | View |
| OROS Research | OR-LPIPA5-426-B4 | Ethos Analytics | 99.00% | MSLALUSP<71>HM | Confirmed by Ethos Analytics | 2026-04-16 | View |
Disclosed Labs